Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042666
Status:
COMPLETED
Last Update Posted:
2020-08-10
First Post:
2002-08-02
Brief Title:
A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2002-08-02
First Submit QC Date:
August 5 2002
Study First Post Date:
2002-08-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-08-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2009-10-16
Disp First Submit QC Date:
October 16 2009
Disp First Post Date:
2009-10-19
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-07-20
Last Update Post Date:
2020-08-10
Last Update Post Date Type:
ACTUAL